Armata Pharmaceuticals (ARMP) Institutional Ownership $2.04 -0.13 (-5.99%) Closing price 04:10 PM EasternExtended Trading$2.06 +0.02 (+1.23%) As of 06:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipSEC FilingsShort InterestBuy This Stock Institutional Ownership Changes (13F Filings) for Armata Pharmaceuticals (NYSEAMERICAN:ARMP)CurrentInstitutional OwnershipPercentage3.57%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)2 Get ARMP Insider Trade Alerts Want to know when executives and insiders are buying or selling Armata Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ARMP Institutional Buying and Selling by Quarter Armata Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Bridgeway Capital Management LLC69,682$129K0.0%-7.6%0.193% 2/13/2025Renaissance Technologies LLC40,291$75K0.0%-13.3%0.111% 4/18/2024SeaCrest Wealth Management LLC32,777$137K0.0%+80.8%0.091% 11/12/2021Renaissance Technologies LLC106,092$384K0.0%-9.1%0.425% 11/9/2021BlackRock Inc.20,571$74K0.0%+928.0%0.082% 11/8/2021Synovus Financial Corp48,060$174K0.0%+108.4%0.193% 8/17/2021Bridgeway Capital Management LLC113,400$450K0.0%+134.3%0.455% 8/13/2021Renaissance Technologies LLC116,696$463K0.0%-5.8%0.468% 8/13/2021Vanguard Group Inc.167,378$665K0.0%+121.4%0.671% 5/21/2021Citadel Advisors LLC21,306$102K0.0%N/A0.085% 5/18/2021Millennium Management LLC15,401$74K0.0%N/A0.062% 5/18/2021Loomis Sayles & Co. L P129,956$621K0.0%N/A0.521% 5/18/2021Citadel Advisors LLC21,306$102K0.0%N/A0.085% 5/13/2021Renaissance Technologies LLC123,816$592K0.0%+25.1%0.496% 5/12/2021Geode Capital Management LLC10,188$48K0.0%N/A0.041% 5/12/2021UBS Group AG6,017$29K0.0%+73.4%0.024% 5/7/2021BlackRock Inc.40,448$194K0.0%+12.4%0.162% (Data available from 1/1/2016 forward) ARMP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ARMP shares? During the previous two years, the following institutional investors and hedge funds held shares of Armata Pharmaceuticals shares: SeaCrest Wealth Management LLC ($137K), and Bridgeway Capital Management LLC ($129K), Renaissance Technologies LLC ($75K).Learn more on Armata Pharmaceuticals' institutional investors. What percentage of Armata Pharmaceuticals' stock is owned by institutional investors? 3.57% of Armata Pharmaceuticals' stock is owned by institutional investors. Learn more on ARMP's institutional investor holdings. Which institutional investors have been buying Armata Pharmaceuticals' stock? The following institutional investors have purchased Armata Pharmaceuticals' stock in the last 24 months: SeaCrest Wealth Management LLC ($14.65K). Which of Armata Pharmaceuticals' major shareholders have been selling company stock? The following institutional investors have sold Armata Pharmaceuticals stock in the last 24 months: Renaissance Technologies LLC ($6.21K), and Bridgeway Capital Management LLC ($5.70K). How much institutional selling is happening at Armata Pharmaceuticals? Institutional investors have sold a total of 11,905 shares in the last 24 months. This volume of shares sold represents approximately $0.00 in transactions. Related Companies 2seventy bio Institutional Ownership ADC Therapeutics Institutional Ownership Annexon Institutional Ownership Amarin Institutional Ownership Inozyme Pharma Institutional Ownership Sagimet Biosciences Institutional Ownership Cartesian Therapeutics Institutional Ownership Corvus Pharmaceuticals Institutional Ownership Palvella Therapeutics Institutional Ownership Neurogene Institutional Ownership This page (NYSEAMERICAN:ARMP) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Armata Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Armata Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ARMP Stock Alerts